Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147277 | SCV000194649 | likely benign | not specified | 2013-10-31 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000147277 | SCV000540035 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
ARUP Laboratories, |
RCV001812118 | SCV001159487 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001511909 | SCV001719231 | benign | SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001788049 | SCV002029896 | benign | Agammaglobulinemia 7, autosomal recessive | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001788051 | SCV002029897 | benign | Immunodeficiency 36 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001788050 | SCV002029898 | benign | SHORT syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000147277 | SCV004102084 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 54% of patients studied by a panel of primary immunodeficiencies. Number of patients: 52. Only high quality variants are reported. |